AntiThrombotic Therapy to Ameliorate Clinical Complications in Community Acquired Pneumonia

NCT05848713 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

4000

Enrollment

OTHER

Sponsor class

Conditions

Community-acquired Pneumonia

Interventions

DRUG: Heparin

Sponsor

University of Manitoba

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]